Welcome to Current Partnering – life science intelligence for deal makers

We are the publisher of CP Reports – life science deal term reports. We also produce Current Agreements – the leading comprehensive partnering, M&A, financing and company database.

In addition, we offer CP Insight – an interactive platform for an advanced level of deal making intelligence, and CP Knowledge Centre – our 3-in-1 life science intelligence package – ideal for users who need comprehensive access to all that Current Partnering has to offer.

New report

Provides comprehensive understanding and unprecedented access to the collaborative R&D partnering deals and agreements entered into by the worlds leading healthcare companies. More

 

Featured partnering deals

Emergent BioSolutions sign a biotech licensing deal with MorphoSys

August 21, 2014 : big biotech, biotech licensing, Emergent BioSolutions

Emergent BioSolutions announced a biotech licensing agreement for the joint development and commercialization of Emergent’s preclinical bi-specific antibody, ES414, targeting prostate cancer. more »

Novartis and TB Alliance sign a pharma licensing agreement

August 21, 2014 : Novartis, pharma licensing, pharma partners, tuberculosis

Novartis has signed an exclusive worldwide pharma licensing agreement with the Global Alliance for TB Drug Development for compounds to fight tuberculosis that have been discovered at the Novartis Institutes for Tropical Diseases. more »

 More partnering deals | all deals at Deal Monitor


Featured M&A deals

Valeant extends the acquisition of Allergan

August 19, 2014 : Allergan, m& A, Valeant

Valeant Pharmaceuticals has extended the acquisition period for Allergan. more »

Alvogen acquired Dream Pharma for $187 million

August 7, 2014 : acquisition, M&A

Alvogen has acquired Dream Pharma in South Korea for US$187 million in cash. more »

 More M&A deals | all deals at Deal Monitor

Featured financing deals

HealthQuest raises $110 million in fundraising financing

August 20, 2014 : financing, financings

HealthQuest Capital announced the end of its debut financing at the hard cap of $110 million. more »

ProQR filed for $75 million in IPO financing

August 18, 2014 : financing, financings, ipo

ProQR Therapeutics filed with the Securities and Exchange Commission to raise $75 million in its initial public offering financing. more »

 More financing deals | all deals at Deal Monitor

Latest Dealtalk

Cubist Pharma, the next acquisition target for big pharmaceuticals

August 19, 2014 : big pharma, Cubist, dealtalk

The timing may be right for a takeover of Cubist Pharmaceuticals. more »

Roche to buy 40% stake in Chugai Pharma

August 18, 2014 : big pharma, dealtalk

Roche Holding is in talks to buy the almost 40 percent of Chugai Pharmaceutical that it doesn’t already own to gain full control of its Japanese partner for oncology and arthritis drugs, according to people familiar with the matter. more »

 More dealtalk

Featured reports

Co-development Terms and Agreements

Publication date: August 2014

Personalized Medicine in Oncology Partnering Terms and Agreements

Publication date: August 2014

Licensing Terms and Agreements

Publication date: August 2014

Diagnostic Imaging Partnering Terms and Agreements

Publication date: August 2014

Trends in Therapeutic Partnering

Publication date: August 2014

Cancer Monoclonal Antibody Terms and Agreements

Publication date: August 2014

Monoclonal Antibody Terms and Agreements

Publication date: August 2014

Co-promotion & Co-marketing Partnering Terms and Agreements

Publication date: July 2014

Drug Delivery Terms and Agreements

Publication date: July 2014

Vaccine Partnering Terms and Agreements

Publication date: July 2014

Distribution Partnering Terms and Agreements

Publication date: July 2014

Diagnostics Partnering Terms and Agreements

Publication date: July 2014

Pharma and Biotech M&A Trends 2009-2014

Publication date: July 2014

Infectious Vaccines Partnering Terms and Agreements

Publication date: June 2014

Antibiotics Partnering Terms and Agreements

Publication date: June 2014

NEW: Therapy deal reports covering all major indications

Including partnering in oncology, cardiovascular, CNS, metabolic, dermatology, dental, infectives, immunologypsychiatry, genitourinary.....plus many others

View all reports

Scorecard

Current Partnering provides access to key deal metrics for all leading partnering, M&A and financings - plus big pharma partnering activity and R&D spend metrics.

Available scorecards:

Partnering

M&A

Financing

Top 50 pharma partnering

Top 50 biotech partnering

Top pharma R&D spend

Deal metrics - by stage of development, therapy area, industry sector

Print Friendly
cpbannerad300x150new1gif
RSS Feed Linked In Twitter

Latest Tweets

cpbannerad300x150new3gif
2014pharmaci-usabanner300x150gif
beu14banner300x150jpg